Litcius/Paper detail

CoronaVac induces lower neutralising activity against variants of concern than natural infection

Vimvara Vacharathit, Pakorn Aiewsakun, Suwimon Manopwisedjaroen, Chanya Srisaowakarn, Thanida Laopanupong, Natali Ludowyke, Angsana Phuphuakrat, Chavachol Setthaudom, Supanuch Ekronarongchai, Sirawat Srichatrapimuk, Pattama Wongsirisin, Suleeporn Sangrajrang, Thanarath Imsuwansri, Suppachok Kirdlarp, Sureeporn Nualkaew, Insee Sensorn, Waritta Sawaengdee, Nuanjun Wichukchinda, Somnuek Sungkanuparph, Wasun Chantratita, Mongkol Kunakorn, Jinda Rojanamatin, Suradej Hongeng, Arunee Thitithanyanont

2021The Lancet Infectious Diseases79 citationsDOIOpen Access PDF

Topics & Concepts

MedicineImmunogenicityTolerabilityVaccinationInternal medicineAntibodyVirologyImmunologyAdverse effectSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies
CoronaVac induces lower neutralising activity against variants of concern than natural infection | Litcius